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Abstract
Invasion of erythrocytes by Plasmodium falciparum involves a complex cascade of protein-protein interactions between
parasite ligands and host receptors. The reticulocyte binding-like homologue (PfRh) protein family is involved in binding to
and initiating entry of the invasive merozoite into erythrocytes. An important member of this family is PfRh5. Using ion-
exchange chromatography, immunoprecipitation and mass spectroscopy, we have identified a novel cysteine-rich protein
we have called P. falciparum Rh5 interacting protein (PfRipr) (PFC1045c), which forms a complex with PfRh5 in merozoites.
Mature PfRipr has a molecular weight of 123 kDa with 10 epidermal growth factor-like domains and 87 cysteine residues
distributed along the protein. In mature schizont stages this protein is processed into two polypeptides that associate and
form a complex with PfRh5. The PfRipr protein localises to the apical end of the merozoites in micronemes whilst PfRh5 is
contained within rhoptries and both are released during invasion when they form a complex that is shed into the culture
supernatant. Antibodies to PfRipr1 potently inhibit merozoite attachment and invasion into human red blood cells
consistent with this complex playing an essential role in this process.
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Introduction
Malaria is caused by parasites from the genus Plasmodium,o f
which Plasmodium falciparum is associated with the most severe form
of the disease in humans. Sporozoite forms of these parasites are
injected into humans during mosquito feeding and they migrate to
the liver where they invade hepatocytes and develop into
merozoites, which are released to invade erythrocytes in the blood
stream. The blood stage cycle of P. falciparum is responsible for all
of the clinical symptoms associated with malaria [1]. Once a
merozoite has invaded an erythrocyte it develops, within this
protected intracellular niche, to form around 16 new merozoites
that are released and then bind and invade other red blood cells.
Invasion of merozoites into the host erythrocyte is a rapid process
involving multiple steps in a cascade of protein-protein interactions
(see for review [2]).
The reticulocyte binding-like homologues (PfRh or PfRBP) and
erythrocyte binding-like (EBL) proteins play important roles in
merozoite invasion [3,4,5,6,7,8,9,10,11,12,13,14,15]. The PfRh
family consists of PfRh1 (PFD0110w), PfRh2a (PF13_0198),
PfRh2b (MAL13P1.176), PfRh3 (PFL2520w), PfRh4 (PFD1150c)
and PfRh5 (PFD1145c) [4,5,7,9,16,17,18,19,20]. PfRh3 is a
transcribed psuedogene in all the P. falciparum strains that have
been analysed [21]. PfRh1, PfRh2b, PfRh2a, PfRh4 and PfRh5
bind to erythrocytes and antibodies to them can inhibit merozoite
invasion thus showing they play a role in this process [11,13,
18,19,20,22,23,24].
Polymorphisms in the PfRh5 protein have been linked to
differential virulence in infection of Aotus monkeys suggesting that
amino acid changes in its binding domain can switch receptor
recognition [19]. PfRh5 has been shown to bind red blood cells
but its putative receptor has not been identified [18,19,20]. In
contrast to other members of the PfRh protein family, PfRh5 is
considerably smaller and lacks a transmembrane region, which
combined with its role as an invasion ligand, suggests it may be
part of a functional complex. It has not been possible to genetically
disrupt the gene encoding PfRh5 and antibodies to it can partially
inhibit merozoite invasion, pointing to an essential role of this
protein in the invasion process [20].
The EBL family of proteins includes EBA-175 (MAL7P1.176)
[3,26], EBA-181 (also known as JESEBL) (PFA0125c) [27,28],
EBA-140 (also known as BAEBL) (MAL13P1.60) [6,29,30,31] and
EBL-1 [32]. Whilst these parasite ligands function in merozoite
invasion by binding to specific receptors on the erythrocyte, they
appear to have a central role in activation of the invasion process.
For example, it has been shown that binding of EBA-175 to its
receptor, glycophorin A restores the basal cytosolic calcium levels
after interaction of the merozoite with the erythrocyte and triggers
PLoS Pathogens | www.plospathogens.org 1 September 2011 | Volume 7 | Issue 9 | e1002199release of rhoptry proteins and it is likely that the PfRh protein
family plays a similar role [37].
The PfRh and EBL protein families are responsible for a
mechanism of phenotypic variation that allows different strains of
P. falciparum to invade erythrocytes using different patterns of host
receptors [7,28,38]. This is important for evasion of host immune
responses and also provides a means to circumvent the poly-
morphic nature of the erythrocyte surface in the human
population [39]. Indeed, analysis of immune responses from
individuals in malaria endemic areas has suggested that the PfRh
proteins are targets of human invasion inhibitory antibodies and
therefore a critical component of acquired protective immunity
[39,40,41].
In order to understand the function of PfRh5 in merozoite
invasion, we purified it from parasite culture supernatant and show
this protein exists as a complex with a cysteine-rich protein
containing 10 epidermal growth factor-like domains (PFC1045c).
This novel protein functions with PfRh5 to play an essential role in
invasion of merozoites into human erythrocytes.
Results
Purification and identification of a PfRh5 complex
PfRh5 binds to erythrocytes and is functionally important in
merozoite invasion of erythrocytes [18,19,20]. Whilst other
members of the PfRh family also bind erythrocytes, they have a
transmembrane region, a feature that PfRh5 lacks suggesting that
it may exist as a complex. In order to determine if PfRh5 was shed
as a complex into culture supernatant during merozoite invasion
we set out to purify it using ion-exchange chromatography. PfRh5,
that had been partially purified from culture supernatant by ion-
exchange chromatography, migrated on SDS-PAGE gels as an
approximately 45 kDa fragment as detected using 2F1, a anti-
PfRh5 specific monoclonal antibody (data not shown), consistent
with our previous results showing that the 63 kDa mature PfRh5
was processed in late schizonts and shed into culture supernatant
during merozoite invasion [20]. However, analysis of PfRh5 by
gel-filtration chromatography revealed that the 45 kDa polypep-
tide was eluted in the peak (# 19–24) (Fig. 1A) which is im-
mediately before the peak of 158 kDa bovine U-globulin (#21–25)
(Fig. S1), suggesting PfRh5 is indeed in a complex with a
molecular weight of approximately 150–200 kDa.
To confirm PfRh5 exists as a higher molecular weight species,
blue native gel electrophoresis was performed and showed the
PfRh5 migrated at an approximate molecular weight of 150–200
kDa (Fig. 1 B). This was in contrast with the processed PfRh1
fragment that migrated at the expected size of 110 kDa (Fig. 1B)
[12]. This suggested that PfRh5 either forms a homo-oligomer or
was in complex with other molecule/s. To distinguish between
these possibilities, gel-filtration chromatography was used to
identify the size increment of PfRh5-containing species after it
was incubated with a monoclonal anti-PfRh5 antibody [20]. It was
found that pre-incubation with anti-PfRh5 antibody caused the
PfRh5 protein peak to appear two fractions earlier, which cor-
respond to an increase in size of the PfRh5-containing species by
150 kDa, indicating that one antibody molecule was associated
with the complex (Fig. 1C and D). The free PfRh5 co-eluted with
the excess antibody in the protein peak comprising fraction 22
to 25 (Fig. 1D), further indicating PfRh5 is in a complex of
approximate 150 kDa. Therefore we proposed that the processed
45 kDa PfRh5 species formed a complex with another molecule/s
rather than existing as a homo-oligomer.
To identify the proteins present within the PfRh5 complex, we
performed a large-scale purification using culture supernatant
from the parasite line 3D7-Rh5HA in which the PfRh5 gene had
been tagged with haemagglutinin epitopes [20]. The PfRh5
protein was enriched and partially purified using ion-exchange
chromatography followed by further purification on an anti-HA
affinity matrix. The bound proteins were eluted and subjected to
trypsin digestion followed by analysis of the resulting peptides by
mass spectrometry (LC-MS/MS) [42]. Since powerful anion ion-
exchange chromatography was employed to enrich the complex
and remove the majority of contaminants before it was subjected
to anti-HA antibody affinity pull-down), the mass spectrometry
analysis yielded a very clean result (Table S1). Database analysis
identified parasite protein peptides that were predominantly
derived from two proteins, which included PfRh5 and a conserved
hypothetical protein (PFC1045c), designated here as P. falciparum
PfRh5 interacting protein (PfRipr) (Table 1 and Table S1). The
most N-terminal peptide found for PfRh5 was amino acid 187–
197, consistent with it being shed into culture supernatant as an
approximately 45 kDa fragment produced by cleavage between
aminoacid 125and135ofthematureprotein.InthecaseofPfRipr,
we identifiedpeptides from both N-terminal and C-terminal regions
of the protein suggesting that the full-length protein was present
within the complex and this was confirmed by co-immunoprecip-
itation experiments with specific antibodies (see below section). The
mature form of PfRipr was 123 kDa and this together with the 45
kDa PfRh5 fragment would produce a complex with an overall
molecular weight of approximately 170 kDa in agreement with the
size observed by gel-filtration chromatography and blue native gel
electrophoresis (Fig. 1A and B). The PfRh5/PfRipr complex was
stably purified by ion-exchange chromatography and 350 mM
NaCl in the elution buffer did not disrupt their association,
suggesting the tight interaction of two proteins. Such specific high
affinity protein-protein interaction implies the biological signifi-
cance of the complex.
PfRh5 and PfRipr form a complex in P. falciparum
In order to confirm that PfRh5 and PfRipr form a complex, we
inserted a plasmid by single cross-over homologous recombination
at the 39 end of the Pfripr gene to fuse three HA epitopes and
derived the parasite line 3D7RiprHA (Fig. 2A) [20]. Successful
tagging was confirmed by immunoblot experiments using anti-HA
antibodies on both saponin lysed schizont pellet preparations and
proteins from culture supernatants (Fig. 2B). In parasite schizont
Author Summary
The malaria parasite invades red blood cells by binding to
proteins on the surface of this host cell. A family of
proteins called P. falciparum reticulocyte binding-like
homologue (PfRh) proteins are important for recognition
of the red blood cell and activation of the invasion process.
An important member of the PfRh family is PfRh5. We have
identified a novel cysteine-rich protein we have called P.
falciparum Rh5 interacting protein (PfRipr), which forms a
complex with PfRh5 in merozoites. PfRipr has 10 epidermal
growth factor-like domains and is expressed in mature
schizont stages where it is processed into two polypep-
tides that associate and form a complex with PfRh5. The
PfRipr protein localises to the apical end of the merozoites
in micronemes whilst PfRh5 is contained within rhoptries
and both are released during invasion when they form a
complex that is released into the culture supernatant.
Antibodies to PfRipr1 can potently inhibit merozoite
attachment and invasion into human red blood cells
consistent with this complex playing an essential role in
this process.
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PLoS Pathogens | www.plospathogens.org 2 September 2011 | Volume 7 | Issue 9 | e1002199Figure 1. The processed 45 kDa PfRh5 C-terminal domain exists as a larger complex. (A) PfRh5 partially purified from parasite culture
supernatant was analysed by size exclusion chromatography on a Superdex 200 analytical column. PfRh5 was eluted from the column as a ,150–200
kDa species. Molecular weight of eluted protein fractions are indicated by arrows as shown using standard proteins of known size. PfRh5 was
detected using 2F1, a specific monoclonal antibody to the protein. (B) Blue native gel electrophoresis confirmed that PfRh5 migrates as a ,150–200
kDa species. The processed PfRh1 fragment of 110 kDa is included as a control. (C) 300 ml of the PfRh5-containing fraction, isolated from culture
supernatant, was loaded onto a Superdex 200 analytical column and eluted with PBS. (D) An identical 300 ml sample was pre-incubated with 25 mgo f
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of approximately 65 kDa were detected whereas in culture
supernatants only the smaller protein band was predominantly
observed. The 125 kDa protein presumably represents the full-
length mature protein in schizonts that was processed and shed
into the culture supernatant. Since only one processed fragment of
65 kDa was detected in culture supernatants using anti-HA
antibody, we propose that PfRipr was processed into at least two
fragments of approximately the same size. Mobility of the 65 kDa
fragment remains similar under the reducing and non-reducing
condition (Fig. 2C) demonstrating that the processed fragments are
not linked by a disulphide bond. Both 65 and 125 kDa fragments
migrated slightly faster on SDS-PAGE gels under non-reducing
conditions consistent with the presence of multiple intramolecular
disulfide linkages creating tightly folded domains (Fig. 2C).
To further confirm that PfRh5 and PfRipr form a complex, we
performed co-immunoprecipitation experiments with anti-PfRh5
and anti-HA antibodies using proteins from the parasite line
3D7RiprHA (Fig. 2D to G). Immunoprecipitation with anti-HA
antibodies, to pull-down tagged PfRipr from schizont-infected
erythrocytes, also brought down PfRh5 as shown by immunoblots
with a specific monoclonal anti-PfRh5 antibody (Fig. 2D). The
full-length mature protein (approximately 63 kDa) as well as two
processed fragments of similar molecular weight (approximately 45
kDa) was observed (Fig. 2D). The reciprocal experiment in which
we immunoprecipitated PfRh5, using the monoclonal anti-PfRh5
antibody, also pulled down PfRipr (Fig. 2E, left panel) but not
PfRh2a or PfRh2b, two other members of PfRh protein family
(Fig. 2E, right panel). Using culture supernatants, a similar
immunoprecipitation experiment with the anti-HA antibodies to
pull down PfRiprHA also co-precipitated the 45 kDa doublet of
PfRh5 but not PfRh2a or PfRh2b (Fig. 2F). The reciprocal
experiment using culture supernatants in which anti-PfRh5
antibody was used for immunoprecipitation detected HA-tagged
PfRiprbutnotPfRh2aorPfRh2binthepull-downsample(Fig.2G).
As an additional control, immunoprecipitaion of the culture
supernatant with rabbit anti-PfRh2a/b antibody recognizing the
85 kDa fragment of both PfRh2a and PfRh2b was performed [24].
The anti-PfRh2a/b antibodies immunoprecipitated the 85 kDa
PfRh2a/b but did not pull-down PfRh5 or PfRipr, further
confirming that the PfRh5/PfRipr complex was specific. It was
not possible to determine with these experiments whether the
PfRipr/PfRh5 proteins associate in schizont stage parasites or at a
later stage. However, since PfRh5 and PfRipr appear to be located
in different compartments within the schizont (see below section), it
is likely that they form a complex during detergent extraction as has
been shown for the AMA1 and RON complex [43,44,45].
PfRipr is a cysteine-rich protein that contains epidermal
growth factor-like domains
PfRipr is highly conserved in Plasmodium spp. and the gene is
syntenic with other genes, all of which are annotatedas hypothetical
(http://plasmodb.org). The full-length PfRipr protein consists of
1,086 amino acids with a molecular weight of 126 kDa. It has a
putative hydrophobic signal sequence at the N-terminus consistent
with it being secreted and the rest of the protein contains 87
cysteine-residues, many of which are clustered in epidermal growth
factor (EGF)-like domains (Fig. 3A and B). There are ten EGF-like
domains in the protein with two in the N-terminal region and eight
clustered towards the C-terminus (Fig. 3A). An EGF domain has 6
cysteine residues and the position of each is relatively conserved in
the ten EGF-like domains of PfRipr (Fig. 3B) [46,47]. Processing of
PfRipr occurs in the area between the second and third EGF-like
domain (Fig. 3A); however, the processed N- and C-terminal
regions remain associated as peptides from both regions were
obtained in the mass spectrometry analysis of the immuno-
precipitated PfRh5/PfRipr complex (Table 1) and the two regions
were co-immunoprecipitated (see below).
The N- and C-terminal domains of PfRipr form a complex
To provide additional tools to probe the function of PfRh5/
PfRipr complex, we expressed amino acids 238–368 of PfRipr that
encompass the two EGF-like domains in the N-terminus as well as
monoclonal anti-PfRh5 antibody before loading onto the same Superdex 200 column. The peak of the eluted PfRh5 protein lies at two preceding
fractions as compared to panel C, corresponding to an increase in molecular weight of ,150 kDa indicating that one antibody molecule was bound
to the PfRh5-containing species. The monoclonal antibody-bound PfRh5 is indicated by an arrow. PfRh5 and the immunoglobulin heavy and light
chain of antibody seen in fraction #22–25 are the free PfRh5 complex and the excess antibody. The asterisks refer to cross-hybridising bands
corresponding to the immunoglobulin heavy and light chain.
doi:10.1371/journal.ppat.1002199.g001
Table 1. Peptides identified by Mass spectrometry from purified PfRh5.
Protein name PlasmoDB Gene number Peptide position Peptide sequence
PfRh5 PFD1145c 187–197 (K)HLSYNSIYHK(S)
212–221 (K)KINETYDKVK(S)
237–247 (K)KLEHPYDINNK(N)
303–310 (K)MMDEYNTK(K)
358–366 (R)YHYDEYIHK(L)
437–443 (K)IIQDKIK(L)
PfRipr PFC1045c 93–100 (K)ScDYFISK(E)
101–114 (K)EYNSSDKTNQIcYK(K)
699–708 (K)LIcQcEEGYK(N)
760–769 (K)MEDGINcIAK(N)
963–972 (K)INcTcKENYK(N)
doi:10.1371/journal.ppat.1002199.t001
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PLoS Pathogens | www.plospathogens.org 4 September 2011 | Volume 7 | Issue 9 | e1002199Figure 2. PfRh5 and PfRipr form a complex. (A) A triple Haemaglutinin (HA) tag was added to the C-terminus of PfRipr by 39 single homologous
crossover recombination. (B) HA-tagged PfRiprHA was detected in the parasite membrane pellet and in the culture supernatant of 3D7PfRiprHA line,
confirming successful tagging. (C) PfRiprHA was analysed by SDS-PAGE under reducing and non-reducing conditions. Similar mobility, of the 65 kDa
C-terminal fragment under both conditions, indicates that the N-terminal and C-terminal of PfRipr was not linked by disulphide bonds after
processing. (D) Co-immunoprecitation of PfRh5 with PfRiprHA was performed using proteins solubilized from saponin pellets of 3D7-PfRiprHA
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domains in the C-terminus (Fig. 3A), in E. coli as a recombinant
protein tagged at the N-terminus with six histidines. The
recombinant proteins of approximately 17 kDa were purified
(Fig. 4A) and used to immunise rabbits. The anti-PfRipr/1 and -
PfRipr/2 IgG antibodies, raised in two rabbits, were tested by
western blot against solubilised pellets from schizont stages and a
protein band of approximately 65 kDa was observed (Fig. 4B).
Specificity of the antibodies was confirmed with HA-tagged PfRipr
immunoprecipitated from culture supernatant with anti-HA anti-
bodies and in both cases a 65 kDa protein was detected (Fig. 4B).
This was the molecular weight expected for the processed C-terminal
schizont-infected erythrocytes. Immunoprecipitation of HA-tagged PfRipr by anti-HA antibody co-immunoprecipitated PfRh5. (E) Immunoprecitation
with anti-PfRh5 antibody using the same schizont materials co-immunoprecipited PfRiprHA but not PfRh2a/b. (F) Co-immnuoprecipitation of PfRh5
with PfRiprHA from culture supernatants using anti-HA-Sepharose bead. Detection of PfRh5 but not PfRh2a or PfRh2b in the anti-HA bead bound
material confirmed that PfRh5 was specifically co-immunoprecipitated with PfRiprHA. (G) Co-immunoprecipitation of PfRiprHA with PfRh5 from
culture supernatants using monoclonal anti-PfRh5 antibody coupled to Mini-beads. Probing of the bound material with anti-HA antibody detected
PfRiprHA only from the 3D7-PfRiprHA parasites and no PfRh2a/b was detected in the bound materials, indicating that PfRiprHA was specifically co-
immunoprecipitated with PfRh5. (H) Immnunoprecipitation of culture supernatant from PfRiprHA parasites with rabbit anti-PfRh2a/b antibodies that
recognize 85 kDa processed PfRh2a/b fragment did not pull-down PfRh5 or PfRipr. In all cases, the asterisk indicates a cross-hybridizing band
corresponding to the heavy chain of IgG eluted from the antibody affinity beads. The arrows in Figure 2E, F and G indicate where 85 kDa PfRh2a/b
band should appear.
doi:10.1371/journal.ppat.1002199.g002
Figure 3. PfRipr protein has ten EGF-like domains. (A) Diagram shows the characteristics of PfRipr and the region used to generate the
recombinant proteins. The arrow corresponds to the approximate position of the PfRipr cleavage site. (B) Alignment of the ten EGF-like domains
within PfRipr.
doi:10.1371/journal.ppat.1002199.g003
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kDa was not easily observed as it was mostly processed at late
schizont stage and in the supernatant. The anti-PfRipr/3 antibody
has low reactivity to the denature protein but recognizes native
PfRipr well.
The anti-PfRipr/3 was therefore used in co-immunoprecipita-
tion experiments to confirm that the cleaved N-terminus and C-
terminus of PfRipr remain associated. Immunoprecipitation of the
HA-tagged C-terminus of PfRipr from 3D7RiprHA parasites using
anti-HA antibodies co-precipitated a fragment of approximately 60
Figure 4. The N-terminal and C-terminal cleaved polypeptides remain associated after cleavage. (A) Amino acids 238-368 and 791-900
of PfRipr that encompassed the N-terminal first two EGF-like domains and C-terminal two EGF-like domains respectively were expressed as
recombinant proteins in E. coli and purified for immunizing rabbits. The proteins were stained with Coomassie blue. (B) Rabbit polyclonal antibodies
(anti-PfRipr/1 and anti-PfRipr/2) raised against the recombinant protein recognize native PfRipr. (C) Rat anti-HA antibody affinity beads were used to
specifically immuno-precipitate proteins solubilized from schizont stages parasites of 3D7 and 3D7RiprHA lines and the bound materials
immunoblotted and probed with rabbit anti-PfRipr/3 antibodies. (D) Rabbit anti-PfRipr/3 antibodies, in conjunction with protein G Sepharose, was
used to specifically immuno-precipitate the proteins solubilized from schizont stages of 3D7 (panel 1) or culture supernatants (panel 2) and then the
bound material was immunoblotted and probed with mouse anti-HA antibodies. The IgG from the pre-bleed serum of the same rabbit was used as a
control. (E) Rabbit anti-PfRipr/3 antibodies, in conjunction with protein G Sepharose, was used to specifically immuno-precipitate the proteins from
culture supernatant of 3D7 and 3D7RiprHA parasites and the bound material immunoblotted and probed with mouse anti-HA antibodies. The
protein marked with a * in the panel D and E is protein G eluted from the beads that cross-reacts with the anti-HA antibodies.
doi:10.1371/journal.ppat.1002199.g004
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fragment is expected for the N-terminal domain of the processed
PfRipr. The full-length mature protein of approximately 125 kDa
was also observed as expected since it should react with both the
anti-PfRipr/3 and anti-HA antibodies. The reciprocal experiment
to immunoprecipitate the N-terminal domain with schizont
material using anti-PfRipr/3 co-precipitated the 65 kDa C-terminal
fragment and the 125 kDa full length protein (Fig. 4D, left panel).
An identical experiment using culture supernatant co-precipitated
the 65 kDa C-terminal domain (Fig. 4D, right panel); the full-length
protein was not detected in this case, presumably because it was
processed. Immunoprecipitation using anti-PfRipr/3 and immuno-
blots with anti-HA antibodies detected the expected bands of the 65
kDa C-terminal domain and the 125 kDa full-length protein in
3D7RiprHA but not from the parental parasite line 3D7 (Fig. 4E),
further confirming the specificity of the antibodies. Together these
experiments show that PfRipr is processed into two fragments of
approximately 65 kDa each and they remain associated with each
other to form a complex with PfRh5, consistent with mass
spectrometry results (Table 1). Their association does not involve
intermolecular disulfide linkages (Fig. 2C).
The anti-PfRipr/1 was used in western blot to probe the PfRipr
separated on a blue native gel (Fig. 5A). Indeed anti-PfRipr/1
recognizes the same protein complex detected by anti-PfRh5, with
the size of the complex (approximately 200 kDa) consistent with
that seen in Fig. 1B.
Expression of PfRipr in the asexual blood stage life cycle was
determined using synchronised ring stages parasites from
3D7RiprHA. Saponin pellets were prepared from the samples
taken during the parasite life cycle as indicated (Fig. 5B). Anti-HA
antibody detected both the 125 kDa full-length and 65 kDa
fragment of PfRipr and expression was evident in late trophozoites
to schizonts, the expected pattern for proteins that play a role in
merozoite invasion [20]. The 65 kDa processed form appeared
late in parasite blood stage development indicating that this pro-
cessing event occurs in the schizont stage before merozoite egress.
The same samples were probed for PfRh5, withwhich PfRipr forms
a complex, and it showed a similar timing of expression but
processing of this protein appears to occur late in schizogony, as
observed earlier [20]. The similar pattern of PfRipr and PfRh5
expression late in the asexual blood stage life cycle of P. falciparum
was consistent with formation of a complex between them either in
the schizont stage or during merozoite egress before interaction of
the parasite with the host cell.
The PfRipr/PfRh5 complex is tightly associated with the
membrane of P. falciparum
Whilst both PfRipr and PfRh5 have a signal sequence at the N-
terminus for entry into the ER, neither has a hydrophobic domain
that would provide the means for anchoring in the membrane. As
PfRh5 binds to the host erythrocyte [18,19,20] it would be
expected that the PfRh5/PfRipr complex would be bound to the
membrane of the merozoite to provide a junction and perhaps
transmit an appropriate signal [37]. To determine if this complex
was associated with a membrane, we used differential solubilisa-
tion of the parasite to determine the properties of the PfRipr/
PfRh5 complex (Fig. 6). P. falciparum parasites were hypotonically
lysed in water and centrifuged to obtain a pellet and supernatant
Figure 5. Protein expression patterns of PfRh5 and PfRipr are consistent with the complex formation. (A) Both anti-PfRh5 and anti-
PfRipr antibodies recognize the same complex resolved by blue native gel electrophoresis. (B) Both PfRh5 and PfRipr are expressed late in the blood
stage life cycle of parasite development. Synchronized PfRiprHA parasites were distributed into six 5 ml cultures. One was harvested immediately
after synchronization (8 – 12 hr ring stage). The second was harvested 16 hr post synchronization, and the third 8 hr later. The rest of the time points
were harvested every 6 hr until the end of growth cycle. Proteins were extracted from saponin pellets, separated by SDS-PAGE and transferred to
nitrocellulose membrane. The membrane was probed with monoclonal anti-HA antibody (top panel) to detect PfRiprHA and then stripped and re-
probed to detect PfRh5 (middle panel) and PfHsp70 (bottom panel). Both PfRh5 and PfRipr proteins are expressed primarily in late schizonts.
doi:10.1371/journal.ppat.1002199.g005
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both PfRipr and PfRh5 remained predominantly in the pellet
fraction suggesting they were associated with a membrane
(Fig. 6A). However, treatment of the pellet fraction with Na2CO3
showed that both proteins moved to the soluble fraction suggesting
they were extrinsically associated as peripheral membrane proteins
of the parasite. PfRipr was mainly insoluble in Triton X-100 but
the smaller processed form of the protein was more soluble in
CHAPs detergent. In contrast, PfRh5 was more soluble in Triton
X-100 and CHAPS implying either PfRipr/PfRh5 complex
involves hydrophobic interactions that can be disrupted by non-
ionic detergents [48], or PfRipr and PfRh5 have different
membrane association properties. Similar solubility characteristics
were obtained from saponin treated parasites isolated with saponin
Figure 6. PfRipr and PfRh5 are peripherally associated with parasite membrane. (A) Differential solubilization of proteins from pellet
prepared by hypotonic lysis of red blood cells that had been infected by the late schitzont stage 3D7-RiprHA parasite. (B) Differential solubilization of
proteins from saponin pellets of late schitzont stage 3D7RiprHA parasites.
doi:10.1371/journal.ppat.1002199.g006
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PfRh5/PfRipr complex was peripherally associated with the
parasite membrane and it is possible that another protein(s) may
be involved in the membrane attachment of the PfRh5/PfRipr
complex.
PfRipr is located in the apical organelles of the merozoite
With anti-PfRipr antibodies, we performed immuno-fluores-
cence assays to determine the subcellular localization of PfRipr
with respect to known markers of compartments such as micro-
nemes and rhoptries, organelles that are important for erythrocyte
invasion. We firstly confirmed that the HA-tagged PfRipr protein
showed the same localisation when detected using both anti-HA
and anti-PfRipr/1 antibodies, with both showing a punctate
pattern in schizonts (Fig. 7, panel a). Co-labelling of schizonts and
merozoites with PfRipr and the rhoptry neck marker RON4
(Fig. 7, panel b and c) or the rhoptry body marker, RAP1 (Fig. 7,
panel d and e), both showed close alignment but no significant
overlap of signal. These results suggest that PfRipr localises to the
apical tip of the merozoite in an area distinct from the very apical
tip and the bulb of the rhoptries. Comparison of the subcellular
localisation of PfRh5 and PfRipr in schizont stages showed that
whilst there appeared to be some overlap, there were substantial
areas of the punctate pattern that were clearly in a separate part of
the cell (Fig. 7, panel f). In contrast, PfRh5 and PfRipr showed
substantial co-localisation in merozoites suggesting that the two
proteins may form a complex in late schitzonts or merozoits (Fig. 7,
panel g). Furthermore, the substantial overlap of PfRipr and the
micronemal protein EBA-175 in the schizont stage suggest that
PfRipr may be predominately present within this organelle at this
stage (Fig. 7, panel h). However, in merozoites they clearly did not
co-localise although there was some overlap (Fig. 7, panel i). Taken
together, these data are consistent with PfRipr localising to
micronemes and being released in merozoites.
To more finely determine the subcellular localisation of PfRipr,
immuno-electron microscopy was performed on 3D7RiprHA
merozoites (Fig 8A to D and Fig. S2). HA-tagged PfRiprHA was
observed towards the apical end of merozoites in more electron
dense structures, suggesting localisation in micronemes (Fig. 8A).
In merozoites fixed during erythrocyte invasion we observed a
concentration of PfRipr reactivity at the leading edge of the tight
junction, consistent with the protein being shed and released into
the culture supernatant during invasion (Fig. 8B). This suggests
that PfRipr was shed from the merozoite surface as the tight
junction moves across its surface so that it concentrates at the
posterior end before sealing of the parasitophorous vacuole
membrane. Whilst there were clearly concentrations of PfRipr in
structures at the apical end (Fig. 8C) we also observed considerable
surface localisation on free merozoites suggesting it is released
prior to invasion (Fig. 8D). In comparison PfRh5 seems to localise
to rhoptries (Fig. 8E, F) as we have observed previously [20];
however, there was also some labelling at the apical surface,
suggesting this protein was also being released prior to invasion
(Fig. 8 E, F). These results are consistent with that observed by
immuno-fluorescent microscopy (Fig. 7). From these localization
data, we suggest that PfRipr and PfRh5 localise to separate
subcellular compartments and thus do not form a complex in
schizont stage parasites. Presumably following fusion, or secretion,
of these distinct compartments, they then come together in
merozoite or late schizont stages. Once complexed and at the
apical end of the merozoite, they interact with a receptor on the
erythrocyte surface. Such an interaction between proteins
originating in separate organelles is not unprecedented, with one
prominent example being the interaction between AMA1 and
RON4 to form the invasion tight junction across apicomplexan
species [43,44,45].
Antibodies to PfRipr inhibit attachment and invasion of P.
falciparum merozoites
To determine if PfRipr was required for development of P.
falciparum, we tested the ability of anti-PfRipr/1 and/2 antibodies
(Fig. 3) to block parasite growth (growth inhibition assays, GIA [7])
using the P. falciparum strains FCR3, W2mef, T994, CSL2, E8B,
MCAMP, 7G8, D10, HB3, and 3D7 (Fig. 9A). The antibodies
inhibited parasite growth of all strains tested and significantly,
FCR3 was inhibited to 80% whilst in comparison 3D7 was
inhibited to 35% with aPfRipr/1 at 2 mg/ml (Fig. 9A). The
inhibition observed for 3D7 was comparable to that observed for
other antibodies raised to regions of the PfRh or EBL protein
families [7,12]. Similar results were observed for 3D7 using the
aPfRipr/2 (data not shown). As for the anti-PfRipr/1 and/2
antibodies, rabbit polyclonal to the N-terminal EGF-like domains
(anti-PfRipr/3) also inhibited parasite growth for all strains tested
(Fig. S3). The aPfRipr/1 antibody was titrated in GIAs in
comparison with IgG from normal serum for both FCR3 and 3D7
parasite strains (Fig. 9B and C). Growth of FCR3, a parasite that
invades preferentially by sialic acid-dependent pathways, was
almost completely abolished at 3 mg/ml and significant inhibition
still remained at 1 mg/ml (40%) (Fig. 9B). In comparison, the 3D7
parasite strain, which can efficiently use sialic acid-independent
invasion pathways primarily by using the ligand PfRh4 and
complement receptor 1 [49], was inhibited at significantly lower
levels of 50% at 3 mg/ml and this decreased to 20% at 1 mg/ml
of antibody (Fig. 9C). This suggests that the PfRipr/PfRh5
complex may be more functionally important in P. falciparum
strains that efficiently use sialic acid-dependent invasion pathways,
which is supported by our finding (Fig. S4) that anti-PfRipr/1
inhibits W2mef, a sialic acid-dependent strain, more effectively
than W2mefD175, a sialic acid-independent strain [8]. Among
other P. falciparum strains tested, the aPfRipr/1 antibody also
exhibited significantly higher inhibitory activity for those that
invade erythrocytes preferentially using sialic acid-dependent
receptors (ie. glycophorins), which includes T994, CSL2 and
E8B (Fig. 9A) [9].
To investigate the mechanism of inhibition by anti-PfRipr
antibodies, we performed merozoite attachment assays (Fig. 9D).
Viable merozoites from 3D7 and FCR3 parasites were purified
[45,50] and mixed with erythrocytes in the presence of aPfRipr/1
or aPfRipr/2 antibodies. Both antibodies inhibited merozoite
attachment for 3D7 to a significant level (45% and 60%
respectively) (Fig. 9D, first panel). In contrast, the same antibodies
inhibited attachment of FCR3 merozoites to a considerably
greater extent (80% for both antibodies) (Fig. 9D, second panel).
The level of inhibitory activity observed with the aPfRipr/1 and
aPfRipr/2 antibodies for 3D7 and FCR3 parasites was similar to
that observed in the growth inhibition assays (Fig. 9A, B and C)
demonstrating that inhibition was occurring at merozoite invasion
rather than during growth of the parasite. This inhibition was
likely due to interference of these antibodies with the function of
the PfRipr/PfRh5 complex since we could not detect PfRipr
binding to erythrocytes while consistently observing PfRh5
binding (data not shown) [20]. It was possible that the PfRipr/
PfRh5 complex disassociated on binding of PfRh5 to red blood
cells. To test this possibility we purified the PfRh5/PfRipr complex
using ion-exchange chromatography (Fig. S5A) and tested its
binding to red blood cells (Fig. S5B). This showed that PfRh5
bound to red blood cells but PfRipr was not detected suggesting
that the complex was disrupted on binding.
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PLoS Pathogens | www.plospathogens.org 11 September 2011 | Volume 7 | Issue 9 | e1002199The region of PfRipr to which the aPfRipr/1, 2 antibodies were
raised was from the 3D7 strain of P. falciparum; however, this
domain does not show any polymorphisms compared to other
strains so far sequenced (http://plasmodb.org/and http://www.
broadinstitute.org/) (Fig. S6). Also we did not observe any cross-
reactivity of the antibodies with other proteins that contain EGF-
like domains such as MSP1 (data not shown). This was not
surprising as the only conserved amino acids are the six cysteine
residues that define each EGF-like domain (Fig. 3). Therefore the
differences in inhibition observed in GIA with the various strains
was unlikely to be due to cross reactivity with other proteins
containing EGF-like domains or polymorphisms within this region
of PfRipr. It more likely reflects the reliance of these strains on the
PfRh5/PfRipr complex to mediate a specific invasion pathway in
comparison to the function of other members of the PfRh and
EBA protein families [7,51]. To test this we used a combination of
antibodies raised to PfRipr, EBA-175 [51], PfRh4 [13,49], PfRh2a
and PfRh2b [7] to determine if they increased the level of
inhibition in GIAs for 3D7 parasites (Fig. 9E). Both aPfRipr/1 and
aPfRipr/2 antibodies at 1 mg/ml inhibited 3D7 parasite growth
to 24 and 21% respectively (Fig. 9E), similar to our previous
experiments (Fig. 9C). Anti-EBA-175 antibodies on its own also
inhibited 3D7 parasite growth to 25%. Anti-PfRh2a/b and PfRh4
antibodies inhibited the 3D7 parasite growth at 39% and 8%
respectively. The combination of aPfRipr/1 with aEBA-175
antibodies showed an additive inhibition of 45%. This was a
similar result to that observed for the combination of aPfRipr/1
with aPfRh2a/b or aPfRh4 antibodies (50% and 40% respective-
ly). Significantly, a combination of aPfRipr/1, aPfRh2a/b and
aPfRh4 as well as aPfRipr/1, aEBA-175, aPfRh2a/b and aPfRh4
showed a much higher level of inhibition (67% and 74%
respectively). This additive effect was consistent with parasites
using multiple invasion pathways to gain entry to the erythrocyte.
A similar additive inhibitory effect was obtained with FCR3
parasites (Fig. S7).
Our inability to disrupt the PfRipr gene (Fig. S8 and S9) suggests
the function of PfRipr and thus the PfRipr/PfRh5 complex is
essential for parasite invasion and survival. Therefore PfRipr
represents a novel protein that plays a critical role in merozoite
invasion and thus it is a new candidate for a combination vaccine
with other PfRh and EBL proteins to produce antibody responses
to block a broad array of invasion pathways.
Discussion
Invasion of P. falciparum into host erythrocytes requires specific
ligand-receptor interactions that identify the appropriate host cell
followed by activation of the parasite actomyosin motor for entry
(see for review [2]). The PfRh family of proteins are important
ligands that bind directly to specific receptors on the red blood cell
during invasion [4,5,7,9,11,13,16,18,19,20,22,49]. Differential
expression and activation of these ligands provide a mechanism
of phenotypic variation to evade host immune responses and to
circumvent the polymorphic nature of the red blood cell surface in
the human population [7,8,39]. PfRh5 is an important member of
the PfRh family that appears to be essential in P. falciparum [19,20].
This ligand binds to an unknown receptor and plays a key role
during merozoite invasion; however, in contrast to all other PfRh
family members, it lacks an identifiable transmembrane region,
suggesting that it may function in a complex with another
protein(s) [20]. We have shown here that PfRh5 exists in a
membrane-associated complex with a novel cysteine-rich protein
that we have called PfRipr.
The ability of PfRipr antibodies to inhibit merozoite attachment
and invasion and our inability to genetically disrupt the cor-
responding gene implies that this protein plays an important role
in these processes. Before invasion, the merozoite undergoes a step
of irreversible attachment to the host red blood cell and current
evidence suggests that the PfRh and EBL protein families play a
key role in this process [37,45]. Attachment triggers down-
stream events presumably through signalling from the cytoplasmic
domain of each molecule [37,45]. Merozoite attachment can be
inhibited with anti-PfRipr antibodies consistent with the PfRh5/
PfRipr complex playing a role in the irreversible binding to
erythrocytes and commitment to invasion. The ability to inhibit
merozoite invasion was not due to cross reactivity of the antibodies
with other proteins such as MSP-1, that also have EGF-like
domains. Whilst neither PfRh5 nor PfRipr has a transmembrane
region they are tightly associated with the membrane, suggesting
they most likely complex with another protein(s) that would hold
the complex on the parasite surface after their release from the
apical organelles. This would link the parasite to the erythrocyte
by binding of PfRh5 to its specific receptor during merozoite
invasion.
The subcellular localisation of PfRh5 and PfRipr appears to be
different in schizont stages of the parasite suggesting that they may
not form a complex until egress of the merozoite and activation of
erythrocyte invasion. PfRh5 was present within the rhoptries
whilst PfRipr appears to be in micronemes at the apical end and
these proteins would be released during apical interaction where
they could associate and form a complex. This is similar to the
formation of the AMA-1 and RON complex in both T. gondii and
P. falciparum where the former protein is located in micronemes
and the latter in the neck of the rhoptries [43,44,52,53].
Components of the RON complex translocate onto and under
the erythrocyte membrane forming a bridge across the host cell to
the invading merozoite through AMA-1 and this is associated with
the tight junction. It is possible that PfRh5/PfRipr interacts with a
membrane associated protein and our immuno-electron micros-
copy analysis has suggested that the complex is at the leading edge
of the tight junction (i.e. basal to the merozoite) and shed into the
culture supernatant, or onto the exterior of the red blood cell,
before membrane fusion to form the enclosing parasitophorous
vacuole membrane at the posterior end of the invading merozoite.
The PfRh and EBL proteins may have overlapping functions as
loss of EBA-175 can be compensated by increased function of
PfRh4 [8,51,54]. Furthermore, different parasite lines can
differentially express these proteins and in some cases polymor-
phisms affect their function or potentially alter receptor selectivity
[7,8,19,28,38]. For example, both PfRh2a and PfRh2b are not
Figure 7. PfRipr localizes to the apical end of merozoites. a) Rabbit polyclonal anti-PfRip antibody (anti-PfRipr/1) recognizes HA-tagged
PfRiprHA. b) PfRipr does not co-localize with the rhoptry neck protein RON4 in schizonts. c) PfRipr does not co-localize with the rhoptry neck protein
RON4 in merozoites. d) PfRipr does not co-localize with the rhoptry bulb protein, RAP1 in schizonts. e) PfRipr does not co-localize with the rhoptry
bulb protein, RAP1 in merozoites. f) PfRipr partially co-localizes with PfRh5 in the schizonts. g) PfRipr mainly co-localizes with PfRh5 in purified
merozoites. h) PfRipr co-localizes with the micronemal marker, EBA175, in schizonts. i) PfRipr does not co-localize with the micronemal marker,
EBA175, in merozoites.
doi:10.1371/journal.ppat.1002199.g007
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PLoS Pathogens | www.plospathogens.org 12 September 2011 | Volume 7 | Issue 9 | e1002199Figure 8. Subcellular localization of PfRipr and PfRh5 by immuno-electron microscopy. (A) Localisation of HA-tagged PfRiprHA using anti-
HA antibodies. The protein localizes to electron dense structures at the apical end of the merozoite that resemble micronemes (arrows). Mn,
micronemes: Rh, rhoptries. (B) PfRiprHA can be detected at the leading edge of the tight junction formed between the erythrocyte and merozoite in a
merozoite in the process of invading a red blood cell. Nu, nucleus: TJ, tight junction. (C) PfRiprHA can be observed concentrating in structures at the
apical end at the periphery of the parasite. Rh, rhoptries. (D) Some merozoites show labeling of PfRipHA on the merozoite surface. (E) and (F)
Localisation of PfRh5 using monoclonal anti-PfRh5 antibody. PfRh5 localises to rhoptries but was also observed at the apical surface, suggesting it
was being released in free merozoites. Rh, Rhoptries. Scale bar is 200 nm.
doi:10.1371/journal.ppat.1002199.g008
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PLoS Pathogens | www.plospathogens.org 13 September 2011 | Volume 7 | Issue 9 | e1002199Figure 9. Antibodies to PfRipr inhibit attachment of merozoites to erythrocytes and parasite growth. (A) Anti-PfRipr/1 antibodies inhibit
invasion of P. falciparum strains into erythrocytes. Shown are growth inhibition assays of the parasite strains FCR3, W2mef, T994, CSL2, E8B, MCAMP,
7G8, D10, HB3 and 3D7. The final antibody concentration is 2 mg/ml. (B) Titration of anti-PfRipr/1 antibodies in growth inhibition assays of the FCR3
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EBA-181 encode polymorphisms that greatly reduce their binding
to the red blood cell surface and render them non-functional when
tested in growth inhibition assays with specific antibodies [55].
Similarly, in the W2mef parasite line PfRh4 is not expressed and
polymorphisms of EBA-140 and EBA-181 also weaken their
binding abilities and function in invasion [55]. Since both FCR3
and W2mef have a reduced complement of functional PfRh and
EBL proteins, one would predict that these parasites would have
greater reliance on the PfRh5/PfRipr complex for their invasion.
That is what we have observed in GIAs with the anti-PfRipr
antibodies that efficiently inhibit merozoite invasion of these
strains. In addition, the additive effect observed with anti-PfRipr
antibody in combination with antibodies raised against other PfRh
and/or EBA in GIAs would be consistent with the PfRh5/PfRip
complex having a similar function to other members of the PfRh
and EBL protein families [54]. However, in contrast to the other
PfRh and EBL proteins, both PfRh5 and PfRipr could not be
genetically disrupted, pointing to the possibility that the complex
may also play a broader role that is essential to the parasites.
The PfRh1, PfRh2a and PfRh2b proteins undergo a complex
series of proteolytic cleavage events in the schizont when trafficked
to the neck of the rhoptries as well as during merozoite invasion
and these events are important in their function [9,12,24]. In the
case of PfRh2a and PfRh2b, the proteins are processed to produce
the N-terminal binding domain that remains associated with the
C-terminal domain [24]. It makes sense for N-terminal binding
domain and C-terminal domain with a transmembrane region to
associate together after processing for the parasites to attach to the
erythrocytes. PfRh5 is also located in the neck of the merozoite
rhoptries and is processed to a 45 kDa binding region [20]. Here
we showed that the 45 kDa binding region forms a complex with
PfRipr. Since neither of them contain a transmembrane region, it
is likely that the complex binds another protein(s) to link it to the
merozoite surface for PfRh5 to bind erythrocyte during invasion.
Our results that the PfRipr/PfRh5 complex is peripherally attached
to the parasite membrane are consistent with this possibility.
Epidermal growth factor-like domains are found widely
throughout eukaryotes and are defined by six cysteine residues
that link to form a tightly folded structure [46,47]. In Plasmodium
spp. this domain is contained in a large number of proteins in
different stages of the parasite lifecycle. The merozoite surface
antigen 1 (MSP-1) has two EGF-like domains and it is localised to
the merozoite surface where antibodies can access it and inhibit
invasion, which has suggested it is involved in interacting with the
erythrocyte surface [56,57]. Other proteins with EGF-like
domains include the P28 family that protect the parasite from
the harsh proteolytic environment in the mosquito gut [58].
PfRipr would not play such a protective role as it is released only
during invasion. Instead, it may act as a scaffold on which PfRh5
can be mounted so that it is displayed for binding to its erythrocyte
receptor. As the N-terminal and C-terminal of PfRipr remains
associated after processing, it is likely that the EGF-like domains
are responsible for their association as well as interaction with
PfRh5. PfRipr has previously been predicted to act as a parasite
adhesin by a bioinformatic method based on protein physiochem-
ical properties [59]. However, we could not detect direct binding
of PfRipr to erythrocytes and our results suggest that the PfRipr/
PfRh5 complex dissociates upon PfRh5 binding to red blood cells.
This may be similar to the processed N-terminus of PfRh2a and
PfRh2b that form a complex with the C-terminus of the same
proteins. However, only the free processed N-terminus can be
detected in erythrocyte binding assays suggesting that this complex
also disassociates [24].
The PfRh and EBL protein families function in binding the
erythrocyte and activating the invasion process [54,55]. It has been
proposed that a combination of these ligands may be a useful blood
stage vaccine against P. falciparum malaria. Indeed it has been shown
in immunisation studies that vaccination with combined portions of
EBA-175, PfRh2a/b and PfRh4 proteins can raise antibodies that
efficientlyblockmerozoiteinvasion[54].Thefunctionalimportance
of PfRh5 has also led to suggestion that it has potential to be
included in such a combination vaccine. However, this has not been
tested due to the difficulty of producing functional protein.
Identification of the PfRh5/PfRipr complex and the ability of
anti-PfRipr antibodies to block merozoite invasion open the
possibility for its inclusion in a combination vaccine. Indeed, the
efficient inhibition of invasion was observed when a combination of
antibodies to PfRipr, PfRh2a/b and PfRh4 was used. This further
supports PfRipr as a new vaccine target, especially in a combination
approach to efficiently block merozoite invasion.
Materials and Methods
Ethics statement
Antibodies were raised in mice and rabbits under the guidelines
of the National Health and Medical Research Committee and the
PHS Policy on Humane Care and Use of Laboratory Animals.
The specific details of our protocol were approved by the Royal
Melbourne Hospital Animal Welfare Committee.
Parasite culture
P. falciparum asexual parasites were maintained in human
erythrocytes (blood group O+) at a hematocrit of 4% with
10%(w/v) AlbumaxTM (Invitrogen) [60]. 3D7 is a cloned line
derived from NF54 from David Walliker at Edinburgh University.
FCR3 is a cloned line. Cultures were synchronised as previously
described [61]. Culture supernatants enriched in parasite proteins
were prepared by growing synchronized parasite cultures to high
parasitemia, typically to 5% and allowing schizonts to rupture.
Harvested culture supernatant was spun at 1200 rpm to remove
residual erythrocytes and then 10,000 rpm to remove insoluble
materials before use for experiments. Total proteins from schizont
stage parasites were obtained by saponin lysis of infected
erythrocytes.
To prepare culture supernatants for affinity purification of the
PfRh5 complex, the PfRh5HA parasite line was synchronized,
grown to late schizont stage in normal culture conditions and then
culture medium was replaced by RPMI without Albumax to allow
the schizonts to rupture [5]. This culture supernatant has a
strain. (C) Titration of anti-PfRipr/1 antibodies in growth inhibition assays of the 3D7 strain. (D) Pre-incubation of purified merozoites from 3D7 strain
(left panel) and FCR3 strain (right panel) with protein-A purified antibodies raised against recombinant PfRipr inhibited merozoite attachment to red
blood cells. Protein-A purified antibodies from normal serum were used as a negative control. The final antibody concentration is 2 mg/ml. (E) Various
combinations of anti-PfRipr/1, EBA-175, PfRh2a/b and PfRh4 antibodies increase inhibitory activity for the 3D7 strain of P. falciparum. The final
concentration of each antibody is 1 mg/ml. In all the cases, each graph represents three independent experiments done in triplicate with each
normalised to the negative control (Protein A purified IgG from normal rabbit serum). The error bars represent standard error of the mean of the
three independent experiments.
doi:10.1371/journal.ppat.1002199.g009
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complex.
Purification and identification of PfRh5 complex
Culture supernatant (900 ml), prepared as described above, was
dialysed against 12.5 mM Tris.Cl pH 7.2 overnight at 4uC and
loaded onto a 15 ml Q-Sepharose column (GE Heathcare)
equilibrated with 12.5 mM Tris.Cl, pH 7.2. The bound proteins
were eluted with NaCl in 12.5 mM Tris.Cl pH 7.2. PfRh5HA was
eluted with 350 mM NaCl. The eluted PfRh5HA-containing
fractions were further purified using anti-HA affinity matrix
(Roche Apply Science) and the bound proteins eluted with 0.1 M
glycine, pH 2.6. The eluted proteins were then subjected to trypsin
digestion and analyzed by mass spectrometry (LC-MS/MS) and
proteins identified by database searches [42].
Gel filtration chromatography and blue native gel
electrophoresis
Gel-filtration chromatography was performed on an analytical
Superdex 200 column (24 ml, GE Healthcare) and proteins were
eluted with PBS or Tris buffer. Blue Native Gel Electrophoresis
was conducted using the company’s protocols (Invitrogen).
NativePAGE
TM Novex 4–16% or 3–12% Bis-Tris gels were used
to resolve the proteins and the NativeMark
TM Unstained Protein
Standard used as molecular weight markers.
Generation of P. falciparum expressing HA-tagged PfRipr
To attach a triple HA tag (3xHA) to the 39 end of the Pfripr
gene, an 844 bp fragment of Pfripr was amplified from 3D7
genomic DNA using the primers 59-ATCCCGCGGTGAATG-
TATATTAAATGATTATTG-39 and 59-TTATCTCGAGATT-
CTGATTACTATAATAAAATACATTTTC-39 (Sac II and Xho I
restriction sites underlined). The DNA fragment was digested with
Sac II and Xho I, and cloned into pHAST, a derivative of pGEM-
3Z containing a 3xHA tag and single Strep II tag in tandem.
Parasites were transfected as described previously [62,63]. Suc-
cessful integration of the 3xHA tag was determined by Southern
and Western blot analysis using a mouse monoclonal anti-HA
antibody.
Immunoprecipitation and immunoblotting
Immunoprecipitation of PfRh5 from culture supernatant was
performed using anti-PfRh5 monoclonal antibody (clone 2F1)
coupled to Minileak resin (KEM-En-Tec). Briefly, 1.5 ml culture
supernatants from both 3D7 and 3D7-PfRiprHA parasite lines
were incubated with 20 ml anti-PfRh5-Minileak resins at 4uC for
4 hr. Also 1.5 ml culture supernatant of 3D7-PfRiprHA parasites
was incubated with just 20 ml Mini-bead as an additional control.
After incubation, the samples were spun to remove the super-
natant and the resin washed three times with PBS containing 0.1%
Tween-20. Bound proteins were eluted with SDS sample buffer
and separated by SDS-PAGE, transferred to nitrocellulose
membrane and probed with a monoclonal anti-HA antibody
(12CA5). The membrane was then stripped and re-probed with
rabbit anti-Rh2a/b polyclonal antibodies recognizing 85 kDa
domain. Immunoprecipitation of HA-tagged PfRipr from culture
supernatant of 3D7-PfRiprHA was performed using rat anti-HA
affinity matrix (Roche Applied Science). The culture supernatants
from 3D7 parasites were used as a control. The bound material
was analysed by western blot to probe for PfRh5 using monoclonal
anti-PfRh5 antibody (2F1) or to probe for PfRipr using polyclonal
antibodies raised against N-terminal fragment (a-PfRip/3). The
material was also probed with anti-Rh2a/b polyclonal antibodies
as a control. Immunoprecipitation of PfRipr from culture super-
natant of 3D7-PfRipHA with a-PfRip/3 was performed using
protein G. The IgG from a pre-bleed of the same rabbit was used
as a control. Immunoprecipitation of PfRipr from solubilised
saponin pellets of the 3D7RiprHA parasite line was performed
similarly. The proteins were extracted from the saponin pellet
using 2% n-Dodecyl-N, N-Dimethylamine-N-Oxide in PBS.
Immunoprecipitation of culture supernatant from 3D7-PfRipHA
with rabbit anti-Rh2a/b polyclonal antibodies was also performed
with protein G. The bound material was probed for PfRh2a,
PfRh2b, PfRh5 and PfRipr using corresponding antibodies raised
in mice. The proteins were detected by enhanced chemilumines-
cence (ECL, Amersham Biosciences).
Analyses of protein expression
Synchronized 3D7RiprHA early ring stage parasites were
harvested and the red blood cells lysed using saponin. A second
aliquot was harvested 16 hr later, the thirdaliquot another 8 hr later
and subsequent samples every 6 hr later until the end of schizogony.
Proteins were extracted from the saponin pellets using SDS-PAGE
sample buffer, separated by 4-12% SDS-PAGE gels (Novagen) and
transferred to a nitrocellulose membrane. The membrane was firstly
probed with monoclonal anti-HA antibody for PfRiprHA and then
stripped to probe for PfRh5 and PfHsp70 [64].
Generation of recombinant PfRipr and antibody
production
To produce recombinant C-terminal fragment of PfRipr
comprise of amino acid 791-900, a 345 bp DNA fragment was
amplified from genomic DNA prepared from 3D7 parasites using
oligonucleotides (59 CGCTAGCCATATGAATGAAGAAACA-
GATATTGTAAAATG 39 and 59 CGAGGATCCCTAATCT-
TCTAAAACACATTTTCC 39). The resulting PCR fragment
was cloned into pET14b vector (Novagen) with Nde I and Bam HI,
transformed into BL21 RIL E. coli strain to express the recom-
binant PfRipr-791-900 as a hexa-His-tagged protein (Fig. 3 A).
The His-tagged protein was purified from soluble lysate of bacteria
cells by affinity purification on Ni-NTA agarose resin (Qiagen)
followed by gel-filtration chromatography on Superdex
TM 75
column. To produce recombinant N-terminal fragment of PfRipr
consisting of amino acid 238–368, a codon-optimised gene was
synthesized and cloned into pET28a vector (Novagen) with Nhe I
and BamHI sites, transformed into BL21 RIL E. coli strain for
expressing recombinant PfRip-238-368 as a hexa-His-tagged
protein. The His-tagged protein was expressed in E. coli as
inclusion body. Protein isolated from inclusion bodies was refolded
in vitro and purified on Ni-NTA agarose resin (Qiagen) under
native conditions. Both purified PfRip-791-900 and PfRip-238-
368 proteins were used to immunise a rabbit. Rabbit immuno-
globulins were purified on Protein A or G-Sepharose and buffer
exchanged to PBS for subsequent experiments. The antibody
production was done by the WEHI antibody production facility.
Immunofluorescence assays
Immunofluorescence assays (IFA) were performed as described
[46], using primary antibodies as follows: rabbit anti-Ripr
[1:1000]; rat anti-HA (monoclonal CF10, Roche) [1:50]; rabbit
anti-RON4 [44] [1:250]; mouse anti-RAP1 [65] [1:500]; mouse
anti-Rh5 2F1 [1:200]; rabbit anti-EBA175 [66] [1:300]. Images
were captured on a Zeiss Axiovert 200 m microscope (Zeiss) with a
100x/1.40NA PlanApochromat phase contrast oil immersion
objective lens (Zeiss), an Axiocam MRm camera (Zeiss) and
running Axiovision version 4.8 software (Zeiss).
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PfRiprHA parasite (late schitzont stage)-infected red blood cells
were hypotonically lysed with water, centrifuged and the pellet
fraction washed with PBS. The pellet was then divided into four
eppendorf tubes and incubated on ice for 2 hr with 10 mM Tris/
pH 8.0; 100 mM sodium carbonate/pH 11.5; 2% Triton X100
and 2% CHAPS in 50 mM Tris/pH8.0 containing 1 mM EDTA
and 100 mM sodium chloride respectively. The samples were then
centrifuged to separate soluble and insoluble fractions. The
insoluble fraction was washed twice with PBS and analyzed by
Western blot together with the soluble fraction. Saponin pellet,
prepared from the late schizont stage PfRiprHA parasites, were
subjected to the same analyses as described above.
Growth inhibition assay (GIA)
GIA were performed as described [67]. Briefly, late trophozoite
stage parasites were added to erythrocytes to give a parasitemia of
0.2% and haematocrit of 2% in 45 ml of 0.5% Albumax II (Gibco,
Auckland, New Zealand) in 96 well round bottom microtiter plates
(Becton Dickinson, Fanklin Lakes, NJ, U.S.A.). 5 ml of purified
rabbit IgG was added to a final concentration of 2 mg/ml. For the
titration experiments, the antibodies were added to a final
concentration of 0.125, 0.25, 0.5, 1, 2.0 and 3.0 mg/ml. Cultures
were incubated for 72 hr (2 cycles) of growth and parasitaemia of
each well was counted by flow cytometry, a FACSCalibur with a
plate reader (Becton Dickinson, Fanklin Lakes, NJ, U.S.A.) after
ethidium bromide (10 mg/ml, Biorad, Hercules, CA, U.S.A)
staining trophozoite stage parasites. For each well, more than
50,000 cells were counted, and all samples were tested in triplicate.
Growth was expressed as a percentage of the parasitaemia
obtained from the pre-immunization IgG control. Three inde-
pendent assays were performed.
Merozoite attachment assay
Merozoite attachment was performed using viable cells purified
as described [45,50]. Briefly, late shizonts of 3D7 and FCR3 (40–
46 hr post invasion) were purified from culture by magnet
separation (Macs Miltenyi Biotec) to .95% purity. The purified
schizonts were incubated with 10 mM E64 (Sigma) for 7–8 hr,
then pelletedat 1900g for5 min. Resultingparasitophorous vacuole
membrane enclosed merozoites (PEMS) [68,69] were resuspended
in a small volume of incomplete culture medium (containing no
protein) and filtered through a 1.2 mm, 32 mm syringe filter
(Sartorius Stedim biotech, France). Antibodies were added to
filtered merozoites at a final concentration of 2 mg/ml and
incubated for 2 min after which uninfected erythrocytes were
added and incubated for 10 min. Following fixation at room
temperature for 30 min using 0.0075% glutaraldehyde/4% para-
formaldehyde (ProSciTech, Australia) in PBS [70] the merozoite-
bound erythrocytes were washed and stained with 0.1 ng/mL4 9,6-
diamidino-2-phenylindole (DAPI) (Invitrogen). Imaging was per-
formed using a either Plan-Apochromat 100x/1.40NA or 40x/
1.3NA oil immersion Phase contrast lens (Zeiss) on an AxioVert
200 M microscope(Zeiss)equipped withan AxioCamMrmcamera
(Zeiss). The MosaiX application from the Axiovision release 4.8
software (Zeiss) was used for counting. For each condition, at least
2000 red blood cells with bound merozoites were scored.
Immuno-Electron microscopy
Merozoites from 3D7RiprHA parsites were purified according
to a previously described method [50] and mixed with uninfected
human erythrocytes. After a 2 min incubation, invading merozo-
ites were fixed in 1% glutaraldehyde (Pro SciTech, Australia) in
RPMI Hepes for 30 min on ice and prepared for Transmission
electron microscopy as described [71]. Briefly, samples were
dehydrated with increasing ethanol concentrations and embedded
in LR Gold resin (Pro SciTech, Australia). The resin was
polymerised using benzoyl peroxide (0.5%) (SPI-Chem, USA)
and the preparation was sectioned on a Leica Ultracut R
ultramicrotome (Wetzlar). The sections were blocked with 5%
BSA and 0.1% Tween-20 in PBS for 30 min. Immunolabeling was
performed with mouse anti-Rh5 clone 6H2 (dilution 1:100) and
mouse anti-HA clone 12AC5 (dilution 1:100). Samples were
incubated with 18 nm colloidal gold-conjugated goat anti-mouse
secondary antibody (Jackson ImmunoResearch, Baltimore, USA).
Post-staining was done with 2% aqueous uranyl acetate and 5%
triple lead and observed at 120 kV on a Philips CM120 BioTWIN
Transmission Electron Microscope.
Supporting Information
Figure S1 Elution profile of protein standards (BioRad).
The protein standards were analysed on the same Superdex 200
analytical column under the same conditions used for analysing
PfRh5 complex shown in Figure 1A.
(TIF)
Figure S2 Subcellular localization of PfRipr by im-
muno-electron microscopy. Additional examples of P.
falciparum 3D7RiprHA merozoites labelled with a primary HA
antibody (mouse 12AC5) and a secondary goat-anti-mouse
antibody conjugated to 18 nm colloidal gold. HA-tagged PfRipr
was localised to the periphery of the parasite (possibly the surface)
and to the interior of the apex of the parasite. Labelling is not
observed inside rhoptries, but some PfRipr is localised adjacent to
rhoptries (A, C), sometimes visible in electron dense bodies near
the parasite apex consistent with micronemes (e.g. panel E), as well
as being distributed around the periphery of free and invading
merozoites. Panel (A) shows a merozoite in the process of invasion.
Panels (B-F) show free merozoites – we are unable to determine
which are more recently released from schizonts, and which are
more mature. Scale bars show 200 nm.
(TIF)
Figure S3 Antibodies to a N-terminal region of PfRipr
inhibit parasite growth. (A) Anti-PfRipr/3 antibodies inhibit
invasion of P. falciparum strains into erythrocytes. Shown are
growth inhibition assays of the parasite strains FCR3, W2mef,
T994, CSL2, E8B, MCAMP, 7G8, D10, HB3 and 3D7. The final
antibody concentration is 2 mg/ml. (B) Titration of anti-PfRipr/3
antibodies in growth inhibition assays of the 3D7 strain.
(TIF)
Figure S4 Anti-PfRipr antibodies inhibit the parasite
growth of a sialic acid-dependent parasite strain (W2mf)
more effectively than a sialic acid-independent strain
(W2mefD175).
(TIF)
Figure S5 PfRh5/PfRipr complex might dissociate upon
PfRh5 binding to erythrocytes. (A) Purification of PfRh5/
PfRipr complex from culture supernatant of 3D7PfRiprHA
parasites by an ion-exchange column. The NaCl eluted fractions
were probed for PfRh5 and PfRipr. (B) Red blood cell binding
assay using PfRh5/PfRipr complex (#6) partially purified from
culture supernatant of 3D7PfRiprHA parasites by the ion-
exchange column. Analyses of eluted fraction detect PfRh5 but
not PfRipr, indicating that PfRh5/PfRipr complex might
dissociate upon PfRh5 binding to erythrocytes.
(TIF)
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falciparum strains. Only positions of amino acid changes
were indicated. Amino acid sequences 238–368 and 791–900 were
used to make recombinant proteins for antibody production.
(TIF)
Figure S7 Additive inhibition of anti-PfRipr/1 in com-
bination with antibodies to EBA-175 or/and PfRh4 for
the FCR3 strain of P. falciparum. The final antibody
concentration is 1 mg/ml. In all the cases, each graph represents
three independent experiments done in triplicate with each
normalised to the negative control (Protein A purified IgG from
normal rabbit serum). The error bars represent standard error of
the mean of the three independent experiments.
(TIF)
Figure S8 Strategy used for the attempted disruption of
the PFC1045c gene in P. falciparum using the plasmid
vector pCC1. The hdhfr cassette would be inserted by
homologous double crossover recombination between the 59 and
39 PFC1045c flanks (black shaded boxes) in the vector and the
endogenous locus. Restriction sites are shown, BamH1, B; Nco 1,
N; EcoR1, E; Afl II, A. WR, WR99210. FC, 59 fluoro-cytosine.
The sizes of the bands expected in Southern blot experiments are
shown in kilobase pairs (kb). The bottom panels are Southern blots
to confirm that integration of the transfected episome had not
happened. The bands in the first panel represent the episomal
plasmid (9 kb) and the intact PFC1045c gene (1 kb). In the 3D7
untransfected line the episomal band is absent as expected;
however, after two cycles both the intact gene and plasmid bands
are obtained when probed with the 59 flank. The second panel
represents a second independent transfection in which no
integration of the transfected pCC1 vector was observed.
(TIF)
Figure S9 PCR analysis of the attempted disruption of
the PFC1045c gene in P. falciparum using the plasmid
vector pCC1. The hdhfr cassette would be inserted by
homologous double crossover recombination between the 59 and
39 PFC1045c flanks (black shaded boxes) in the vector and the
endogenous locus. PCR analysis of genomic DNA from 3D7
transfected with pCC1-PFC1045c that confers resistance to
WR99210 and sensitivity to 5-Fluro-cytosine. For 3D7 the
endogenous gene was detected with p405/p338 oligonucleotide
primers (1454 bp), whilst for 3D7DPFC1045c the PCR product if
present would be detected with p403/p560 (1373 bp), and this
would represent integration of the hdhfr gene and disruption of
PFC1045c. In the case of 3D7 transfected with pCC1-PFC1045c a
PCR product was observed for wild type, but not for the event
corresponding to integration by homologous recombination. PCR
oligonucleotide pairs p403/p338 and p335/p388 were used as
specificity controls. Both PCR oligonucleotide pairs produced
PCR products of the expected size.
(TIF)
Table S1 Mass spectrometry identification of PfRh5
complex. A list of all proteins identified by mass spectrometry
from the PfRh5 purified complex.
(DOC)
Acknowledgments
We thank the Red Cross Blood Service (Melbourne, Australia) for supply of
red blood cells and serum and the Walter and Eliza Hall Institute of
Medical Research Monoclonal Laboratory for growing the monoclonal
antibodies. We thank Dr. Brian Smith (WEHI) for advice on determining
the EGF domains of PfRipr, Ms Heather Patsiouras for MS analyses and
Dr Kelly Rogers for assistance with immunofluorescence assays.
Author Contributions
Conceived and designed the experiments: LC SL DTR CD ADU WHT
MTO DR JB SAR AFC. Performed the experiments: LC SL DTR CD
ADU WHT MTO DR SAR. Analyzed the data: LC SL DTR CD ADU
WHT MTO DR JB SAR AFC. Wrote the paper: LC WHT AFC.
References
1. Miller LH, Greenwood B (2002) Malaria–a shadow over Africa. Science 298:
121–122.
2. Cowman AF, Crabb BS (2006) Invasion of red blood cells by malaria parasites.
Cell 124: 755–766.
3. Sim BKL, Orlandi PA, Haynes JD, Klotz FW, Carter JM, et al. (1990) Primary
structure of the 175K Plasmodium falciparum erythrocyte binding antigen and
identification of a peptide which elicits antibodies that inhibit malaria merozoite
invasion. J Cell Biol 111: 1877–1884.
4. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW (2001) A
Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein
(PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J Exp Med
194: 1571–1581.
5. Triglia T, Thompson J, Caruana SR, Delorenzi M, Speed T, et al. (2001)
Identification of proteins from Plasmodium falciparum that are homologous
to reticulocyte binding proteins in Plasmodium vivax.I n f e c tI m m u n6 9 :
1084–1092.
6. Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, et al. (2003)
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection
for Gerbich negativity in human populations. Nat Med 9: 87–92.
7. Duraisingh MT, Triglia T, Ralph SA, Rayner JC, Barnwell JW, et al. (2003)
Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor
targeting for invasion of human erythrocytes. EMBO J 22: 1047–1057.
8. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, et al. (2005) Molecular
mechanism for switching of P. falciparum invasion pathways into human
erythrocytes. Science 309: 1384–1387.
9. Triglia T, Duraisingh MT, Good RT, Cowman AF (2005) Reticulocyte-binding
protein homologue 1 is required for sialic acid-dependent invasion into human
erythrocytes by Plasmodium falciparum. Mol Microbiol 55: 162–174.
10. Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, et al. (2006) Upregulation of
expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone
Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol
Biochem Parasitol 145: 205–215.
11. Gao X, Yeo KP, Aw SS, Kuss C, Iyer JK, et al. (2008) Antibodies targeting the
PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites.
PLoS Pathog 4: e1000104.
12. Triglia T, Tham WH, Hodder A, Cowman AF (2009) Reticulocyte binding
protein homologues are key adhesins during erythrocyte invasion by Plasmodium
falciparum. Cell Microbiol 11: 1671–1687.
13. Tham WH, Wilson DW, Reiling L, Chen L, Beeson JG, et al. (2009) Antibodies
to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium
falciparum into human erythrocytes. Infect Immun 77: 2427–2435.
14. DeSimone TM, Bei AK, Jennings CV, Duraisingh MT (2009) Genetic analysis
of the cytoplasmic domain of the PfRh2b merozoite invasion protein of
Plasmodium falciparum. Int J Parasitol 39: 399–405.
15. Desimone TM, Jennings CV, Bei AK, Comeaux C, Coleman BI, et al. (2009)
Cooperativity between Plasmodium falciparum adhesive proteins for invasion into
erythrocytes. Mol Microbiol 72: 578–589.
16. Rayner JC, Galinski MR, Ingravallo P, Barnwell JW (2000) Two Plasmodium
falciparum genes express merozoite proteins that are related to Plasmodium vivax
and Plasmodium yoelii adhesive proteins involved in host cell selection and
invasion. Proc Natl Acad Sci USA 97: 9648–9653.
17. Kaneko O, Mu J, Tsuboi T, Su X, Torii M (2002) Gene structure and
expression of a Plasmodium falciparum 220-kDa protein homologous to the
Plasmodium vivax reticulocyte binding proteins. Mol Biochem Parasitol 121:
275–278.
18. Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA (2008) PfRH5: a
novel reticulocyte-binding family homolog of Plasmodium falciparum that binds to
the erythrocyte, and an investigation of its receptor. PLoS ONE 3: e3300.
19. Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, et al. (2008) Erythrocyte
binding protein PfRH5 polymorphisms determine species-specific pathways of
Plasmodium falciparum invasion. Cell Host Microbe 4: 40–51.
20. Baum J, Chen L, Healer J, Lopaticki S, Boyle M, et al. (2009) Reticulocyte-
binding protein homologue 5-an essential adhesin involved in invasion of human
erythrocytes by Plasmodium falciparum. Int J Parasitol 39: 371–380.
An EGF-like Protein that Binds PfRh5 during Invasion
PLoS Pathogens | www.plospathogens.org 18 September 2011 | Volume 7 | Issue 9 | e100219921. Taylor HM, Triglia T, Thompson J, Sajid M, Fowler R, et al. (2001) Plasmodium
falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii
adhesive proteins, which is transcribed but not translated. Infect Immun 69:
3635–3645.
22. Gaur D, Singh S, Singh S, Jiang L, Diouf A, et al. (2007) Recombinant
Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and
blocks invasion. Proc Natl Acad Sci U S A 104: 17789–17794.
23. Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, et al. (2011)
Plasmodium falciparum Reticulocyte Binding-Like Homologue Protein 2 (PfRH2) Is
a Key Adhesive Molecule Involved in Erythrocyte Invasion. PLoS ONE 6:
e17102.
24. Triglia T, Chen L, Lopaticki S, Dekiwadia C, Riglar DT, et al. (2011) Plasmodium
falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a
and b binding domains. Plos Pathogen In Press.
25. Spadafora C, Awandare GA, Kopydlowski KM, Czege J, Moch JK, et al. (2010)
Complement receptor 1 is a sialic acid-independent erythrocyte receptor of
Plasmodium falciparum. PLoS Pathog 6: e1000968.
26. Orlandi PA, Sim KL, Chulay JD, Haynes JD (1990) Characterization of the
175-kilodalton erythrocyte binding antigen of Plasmodium falciparum.M o l
Biochem Parasitol 40: 285–294.
27. Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, et al.
(2003) A novel erythrocyte binding antigen-175 paralogue from Plasmodium
falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol
Chem 278: 14480–14486.
28. Mayer DC, Mu JB, Kaneko O, Duan J, Su XZ, et al. (2004) Polymorphism in
the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its
receptor specificity. Proc Natl Acad Sci U S A 101: 2518–2523.
29. Thompson JK, Triglia T, Reed MB, Cowman AF (2001) A novel ligand from
Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface
of human erythrocytes. Mol Micro 41: 47–58.
30. Mayer DC, Kaneko O, Hudson-Taylor DE, Reid ME, Miller LH (2001)
Characterization of a Plasmodium falciparum erythrocyte-binding protein para-
logous to EBA-175. Proc Natl Acad Sci U S A 98: 5222–5227.
31. Narum DL, Fuhrmann SR, Luu T, Sim BK (2002) A novel Plasmodium falciparum
erythrocyte binding protein-2 (EBP2/BAEBL) involved in erythrocyte receptor
binding. Mol Biochem Parasitol 119: 159–168.
32. Mayer DC, Cofie J, Jiang L, Hartl DL, Tracy E, et al. (2009) Glycophorin B is
the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand,
EBL-1. Proc Natl Acad Sci USA 106: 5348–5352.
33. Orlandi PA, Klotz FW, Haynes JD (1992) A malaria invasion receptor, the 175-
kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the
terminal Neu5Ac(alpha2-3)Gal- sequences of glycophorin A. J Cell Biol 116:
901–909.
34. Adams JH, Sim BKL, Dolan SA, Fang X, Kaslow DC, et al. (1992) A family of
erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89:
7085–7089.
35. Sim BKL, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH (1994) Receptor
and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science
264: 1941–1944.
36. Lobo CA, Rodriguez M, Reid M, Lustigman S (2003) Glycophorin C is the
receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl).
Blood 6: 6.
37. Singh S, Alam MM, Pal-Bhowmick I, Brzostowski JA, Chitnis CE (2010)
Distinct external signals trigger sequential release of apical organelles during
erythrocyte invasion by malaria parasites. PLoS Pathog 6: e1000746.
38. Mayer DC, Mu JB, Feng X, Su XZ, Miller LH (2002) Polymorphism in a
Plasmodium falciparum erythrocyte-binding ligand changes its receptor specificity.
J Exp Med 196: 1523–1528.
39. Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, et al. (2008)
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum
mediates evasion of human inhibitory antibodies. J Clin Invest 118: 342–351.
40. Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, et al. (2010) Evidence
that the erythrocyte invasion ligand PfRh2 is a target of protective immunity
against Plasmodium falciparum malaria. J Immunol 185: 6157–6167.
41. Richards JS, Stanisic DI, Fowkes FJ, Tavul L, Dabod E, et al. (2011) Association
between naturally acquired antibodies to erythrocyte-binding antigens of
Plasmodium falciparum and protection from malaria and high-density
parasitemia. Clin Infect Dis 51: e50–60.
42. Boddey JA, Moritz RL, Simpson RJ, Cowman AF (2009) Role of the Plasmodium
export element in trafficking parasite proteins to the infected erythrocyte. Traffic
10: 285–299.
43. Alexander DL, Arastu-Kapur S, Dubremetz JF, Boothroyd JC (2006) Plasmodium
falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a
component of the moving junction in Toxoplasma gondii. Eukaryot Cell 5:
1169–1173.
44. Richard D, MacRaild CA, Riglar DT, Chan JA, Foley M, et al. (2010)
Interaction between Plasmodium falciparum apical membrane antigen 1 and the
rhoptry neck protein complex defines a key step in the erythrocyte invasion
process of malaria parasites. J Biol Chem 285: 14815–14822.
45. Riglar DT, Richard D, Wilson DW, Boyle MJ, Dekiwadia C, et al. (2011) Super-
resolution dissection of coordinated events during malaria parasite invasion of
the human erythrocyte. Cell Host Microbe 9: 9–20.
46. Savage CR, Jr., Inagami T, Cohen S (1972) The primary structure of epidermal
growth factor. J Biol Chem 247: 7612–7621.
47. Savage CR, Jr., Hash JH, Cohen S (1973) Epidermal growth factor. Location of
disulfide bonds. J Biol Chem 248: 7669–7672.
48. Harada Y, Li H, Wall JS, Lennarz WJ (2011) Structural studies and the assembly
of the heptameric post-translational translocon complex. J Biol Chem 286:
2956–2965.
49. Tham WH, Wilson DW, Lopaticki S, Schmidt CQ, Tetteh-Quarcoo PB, et al.
(2010) Complement receptor 1 is the host erythrocyte receptor for Plasmodium
falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A 107: 17327–17332.
50. Boyle MJ, Wilson DW, Richards JS, Riglar DT, Tetteh KK, et al. (2010)
Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion
events and advance vaccine and drug development. Proc Natl Acad Sci U S A
107: 14378–14383.
51. Baum J, Maier AG, Good RT, Simpson KM, Cowman AF (2005) Invasion by P.
falciparum merozoites suggests a hierarchy of molecular interactions. PLoS
Pathog 1: e37.
52. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC (2005) Identification
of the moving junction complex of Toxoplasma gondii: a collaboration between
distinct secretory organelles. PLoS Pathog 1: e17.
53. Besteiro S, Michelin A, Poncet J, Dubremetz JF, Lebrun M (2009) Export of a
Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to
form the moving junction during invasion. PLoS Pathog 5: e1000309.
54. Lopaticki S, Maier AG, Thompson J, Wilson DW, Tham WH, et al. (2011)
Reticulocyte and erythrocyte binding-like proteins function cooperatively in
invasion of human erythrocytes by malaria parasites. Infect Immun 79:
1107–1117.
55. Maier AG, Baum J, Smith B, Conway DJ, Cowman AF (2009) Polymorphisms
in erythrocyte binding antigens 140 and 181 affect function and binding but not
receptor specificity in Plasmodium falciparum. Infect Immun 77: 1689–1699.
56. Holder AA (1988) The precursor to major merozoite surface antigens: structure
and role in immunity. Prog Allergy 41: 72–97.
57. Chitarra V, Holm I, Bentley G, Petres S, Longacre S (1999) The crystal
structure of the C-terminal merozoite protein 1 at 1.8A resolution, a highly
protective malaria vaccine candidate. Mol Cell 3: 457–464.
58. Tomas AM, Margos G, Dimopoulos G, van Lin LH, de Koning-Ward TF, et al.
(2001) P25 and P28 proteins of the malaria ookinete surface have multiple and
partially redundant functions. EMBO J 20: 3975–3983.
59. Ansari FA, Kumar N, Bala Subramanyam M, Gnanamani M, Ramachandran S
(2008) MAAP: malarial adhesins and adhesin-like proteins predictor. Proteins
70: 659–666.
60. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture.
Science 193: 673–675.
61. Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum
erythrocytic stages in culture. J Parasitol 65: 418–420.
62. Crabb BS, Cooke BM, Reeder JC, Waller RF, Caruana SR, et al. (1997)
Targeted gene disruption shows that knobs enable malaria-infected red cells to
cytoadhere under physiological shear stress. Cell 89: 287–296.
63. Voss TS, Healer J, Marty AJ, Duffy MF, Thompson JK, et al. (2006) A var gene
promoter controls allelic exclusion of virulence genes in Plasmodium falciparum
malaria. Nature 439: 1004–1008.
64. Bianco AE, Favaloro JM, Burkot TR, Culvenor JG, Crewther PE, et al. (1986) A
repetitive antigen of Plasmodium falciparum that is homologous to heat shock
protein 70 of Drosophila melanogaster. Proc Natl Acad Sci USA 83: 8713–8717.
65. Schofield L, Bushell GR, Cooper JA, Saul AJ, Upcroft JA, et al. (1986) A rhoptry
antigen of Plasmodium falciparum contains conserved and variable epitopes
recognized by inhibitory monoclonal antibodies. Mol Biochem Parasitol 18:
183–195.
66. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, et al. (2000)
Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is
associated with a switch toward a sialic acid independent pathway of invasion.
Proc Natl Acad Sci USA 97: 7509–7514.
6 7 .P e r s s o nK E ,L e eC T ,M a r s hK ,B e e s o nJ G( 2 0 0 6 )D e v e l o p m e n ta n d
optimization of high-throughput methods to measure Plasmodium falciparum-
specific growth inhibitory antibodies. J Clin Microbiol 44: 1665–1673.
68. Salmon BL, Oksman A, Goldberg DE (2001) Malaria parasite exit from the host
erythrocyte: A two- step process requiring extraerythrocytic proteolysis. Proc
Natl Acad Sci U S A 98: 271–276.
69. Wickham ME, Culvenor JG, Cowman AF (2003) Selective inhibition of a two-
step egress of malaria parasites from the host erythrocyte. J Biol Chem 278:
37658–37663.
70. Tonkin CJ, van Dooren GG, Spurck TP, Struck NS, Good RT, et al. (2004)
Localization of organellar proteins in Plasmodium falciparum using a novel set of
transfection vectors and a new immunofluorescence fixation method. Mol
Biochem Parasitol 137: 13–21.
71. Healer J, Crawford S, Ralph S, McFadden G, Cowman AF (2002) Independent
translocation of two micronemal proteins in developing Plasmodium falciparum
merozoites. Infect Immun 70: 5751–5758.
An EGF-like Protein that Binds PfRh5 during Invasion
PLoS Pathogens | www.plospathogens.org 19 September 2011 | Volume 7 | Issue 9 | e1002199